Pharmaceutical Intelligence

Curator: Aviva Lev-Ari, PhD, RN WORK-IN-PROGRESS Explosion of Podcasts on the topic include the following Selected list: How AI Is Transforming Healthcare, Biotech and the Future of Medicine Forbes Jun 7, 2026 AI-driven innovation is rapidly reshaping the scientific ecosystem and redefining long-term value creation across healthcare, biotech, and life sciences.

J. Michael Bishop, MD, a Fellow of the AACR Academy who shared the Nobel Prize for Physiology or Medicine in 1989 with Harold E. Varmus, MD, for their discovery of the cellular origin of retroviral oncogenes, died March 20, 2026, at the age of 90. Bishop served as chancellor of the University of California, San Francisco, from 1998 until he retired in 2009. He presided over a major expansion of UCSF, a university that is devoted entirely to biomedical sciences.

Watch VIDEO Artificial intelligence could help scientists develop better medicines faster—and thus improve millions of people’s lives. But for that to happen, companies will need to change the way they work. Below is a Mckinsey report on How AI will Change the Future of Biotech https://www.mckinsey.com/featured-insights/the-next-normal/biotech Human bodies are incredibly complex. It takes many years to discover even just one new medicine to successfully treat a disease.

Curators: Aviva Lev-Ari, PhD, RN with Grok Assistence As the race to build powerful biology foundation models intensifies, several well-funded AI-native companies have emerged with ambitious platforms for protein design, small-molecule generation, and multimodal drug discovery. While these companies bring strong technical capabilities, LPBI Group occupies a distinct and complementary position in the ecosystem.

In Memoriam: In Remembrance of Cancer Researchers who passed in 2026 July 13, 2026 by sjwilliamspa In Memoriam: In Remembrance of Cancer Researchers who passed in 2026 Reporter: Stephen J. Williams, Ph.D. Source: https://www.aacr.org/professionals/membership/in-memoriam/ The following remembrances of American Association of Cancer Research (AACR) prominent member who have recently passed in 2026 is given below.

To the Membership of Life Sciences PA: Today, we are urging you to contact your United States members of Congress on Office of Management and Budget (OMB) proposed revisions to “Guidance for Federal Financial Assistance.” You can do so through the Life Sciences PA Advocacy Action Center. The OMB proposal, which is currently accepting public comments, would make significant changes to how research funding decisions are administered across federal agencies, including the NIH and NSF.

Reporter: Stephen J. Williams, Ph.D. From the Tang Prize Committee Anouncement Source: https://www.tang-prize.org/en/media_detail.php?id=2097 On June 16, the Tang Prize in Biopharmaceutical Science announced its 2026 laureates. The prize, whose laureates from previous cycles have subsequently received Nobel Prize honors, has drawn wide international attention. Three leading scientists in the field of cellular immunotherapy, Drs. Steven A. Rosenberg, Michel Sadelain, and Carl H.

This content is password-protected. To view it, please enter the password below.

Tumor Infiltrating Lymphocytes (TIL) as a first of kind FDA approved immunotherapy for cancer June 12, 2026 by sjwilliamspa Reporter: Stephen J.

Curators: Aviva Lev-Ari, PhD, RN and Grok/xAI This post presents a systematic, day-by-day analysis of the daily newsletters published by Alex Wissner-Gross, Investor and Entrepreneur, covering the period from March 1, 2026 through June 10, 2026, and extended to the present. This body of work represents a new format of Hybrid Scientific Reporting for LPBI Group. It combines continuous real-time observation of the AI revolution with structured strategic reasoning and documentation.